2006.07.007 Lazzaro, B.P., Zasloff, M., and Rolff, J., Science , 2020, vol
Through structural innovation and international collaboration, Hansoh Pharmas HS-10535 demonstrates strong technological competitiveness in the small-molecule GLP-1 receptor agonist sector
References Quality & Purity This product is synthesized via solid-phase peptide synthesis (SPPS) and tested to 99% purity by HPLC with identity confirmed by mass spectrometry
Hu et al 2016
For BPC-157, numerous investigations in rodent models have demonstrated therapeutic benefits in wound healing, tendon repair, and gastrointestinal protection
No es un medicamento, suplemento, cosmtico, alimento ni producto de consumo humano